372 related articles for article (PubMed ID: 9169661)
1. Neural cell adhesion molecule (CD56)-positive acute myelogenous leukemia and myelodysplastic and myeloproliferative syndromes.
Mann KP; DeCastro CM; Liu J; Moore JO; Bigner SH; Traweek ST
Am J Clin Pathol; 1997 Jun; 107(6):653-60. PubMed ID: 9169661
[TBL] [Abstract][Full Text] [Related]
2. Gene rearrangements in bone marrow cells of patients with acute myelogenous leukemia.
Schmetzer HM; Braun S; Wiesner D; Duell T; Gerhartz HH; Mittermueller J
Acta Haematol; 2000; 103(3):125-34. PubMed ID: 10940650
[TBL] [Abstract][Full Text] [Related]
3. Detection of acute leukemia cells with mixed lineage leukemia (MLL) gene rearrangements by flow cytometry using monoclonal antibody 7.1.
Wuchter C; Harbott J; Schoch C; Schnittger S; Borkhardt A; Karawajew L; Ratei R; Ruppert V; Haferlach T; Creutzig U; Dörken B; Ludwig WD
Leukemia; 2000 Jul; 14(7):1232-8. PubMed ID: 10914547
[TBL] [Abstract][Full Text] [Related]
4. Acute myeloid leukemia with MLL rearrangements: clinicobiological features, prognostic impact and value of flow cytometry in the detection of residual leukemic cells.
Muñoz L; Nomdedéu JF; Villamor N; Guardia R; Colomer D; Ribera JM; Torres JP; Berlanga JJ; Fernández C; Llorente A; Queipo de Llano MP; Sánchez JM; Brunet S; Sierra J;
Leukemia; 2003 Jan; 17(1):76-82. PubMed ID: 12529663
[TBL] [Abstract][Full Text] [Related]
5. Acute myeloid leukemia with 11q23 translocations: myelomonocytic immunophenotype by multiparameter flow cytometry.
Baer MR; Stewart CC; Lawrence D; Arthur DC; Mrózek K; Strout MP; Davey FR; Schiffer CA; Bloomfield CD
Leukemia; 1998 Mar; 12(3):317-25. PubMed ID: 9529125
[TBL] [Abstract][Full Text] [Related]
6. Blast counts are lower in the aspirate as compared to trephine biopsy in acute myeloid leukemia and myelodysplastic syndrome expressing CD56.
Drexler B; Tzankov A; Martinez M; Baerlocher S; Passweg JR; Dirnhofer S; Tsakiris DA; Dirks J
Int J Lab Hematol; 2021 Oct; 43(5):1078-1084. PubMed ID: 33709561
[TBL] [Abstract][Full Text] [Related]
7. ETV6 rearrangements are recurrent in myeloid malignancies and are frequently associated with other genetic events.
Haferlach C; Bacher U; Schnittger S; Alpermann T; Zenger M; Kern W; Haferlach T
Genes Chromosomes Cancer; 2012 Apr; 51(4):328-37. PubMed ID: 22162288
[TBL] [Abstract][Full Text] [Related]
8. 11q23 abnormalities in patients with acute myelogenous leukemia and myelodysplastic syndrome as detected by molecular and cytogenetic analyses.
Ibrahim S; Estey EH; Pierce S; Glassman A; Keating M; O'Brien S; Kantarjian HM; Albitar M
Am J Clin Pathol; 2000 Nov; 114(5):793-7. PubMed ID: 11068555
[TBL] [Abstract][Full Text] [Related]
9. Double minute chromosomes in acute myeloid leukemia, myelodysplastic syndromes, and chronic myelomonocytic leukemia are associated with micronuclei, MYC or MLL amplification, and complex karyotype.
Huh YO; Tang G; Talwalkar SS; Khoury JD; Ohanian M; Bueso-Ramos CE; Abruzzo LV
Cancer Genet; 2016; 209(7-8):313-20. PubMed ID: 27318442
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cell (NK) subsets and NK-like T-cell populations in acute myeloid leukemias and myelodysplastic syndromes.
Aggarwal N; Swerdlow SH; TenEyck SP; Boyiadzis M; Felgar RE
Cytometry B Clin Cytom; 2016 Jul; 90(4):349-57. PubMed ID: 26648320
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of p53, mdm2, waf1/p21, and Ki67 proteins in bone marrow biopsies in myelodysplastic syndroms, acute myelogenous leukaemias and chronic myeloproliferative disorders.
Kanavaros P; Stefanaki K; Rontogianni D; Darivianaki K; Vlychou M; Papadaki E; Eliopoulos G; Bakiri M; Matsouka C; Kakolyris S; Georgoulias V
Clin Exp Pathol; 1999; 47(5):231-8. PubMed ID: 10598372
[TBL] [Abstract][Full Text] [Related]
12. Relapse and cytogenetic evolution in myeloid neoplasms.
Ertz-Archambault N; Kelemen K
Panminerva Med; 2017 Dec; 59(4):308-319. PubMed ID: 29144072
[TBL] [Abstract][Full Text] [Related]
13. MLL gene amplification in acute myeloid leukemia and myelodysplastic syndromes is associated with characteristic clinicopathological findings and TP53 gene mutation.
Tang G; DiNardo C; Zhang L; Ravandi F; Khoury JD; Huh YO; Muzzafar T; Medeiros LJ; Wang SA; Bueso-Ramos CE
Hum Pathol; 2015 Jan; 46(1):65-73. PubMed ID: 25387813
[TBL] [Abstract][Full Text] [Related]
14. Granulocytic sarcoma in MLL-positive infant acute myelogenous leukemia: fluorescence in situ hybridization study of childhood acute myelogenous leukemia for detecting MLL rearrangement.
Park KU; Lee DS; Lee HS; Kim CJ; Cho HI
Am J Pathol; 2001 Dec; 159(6):2011-6. PubMed ID: 11733351
[TBL] [Abstract][Full Text] [Related]
15. A case of acute myelogenous leukemia: myelodysplastic syndrome with t(2;11)(p21;q23) without MLL rearrangement.
Gozzetti A; Tozzuoli D; Crupi R; Raspadori D; Fabbri A; Lauria F
Cancer Genet Cytogenet; 2003 Jul; 144(2):177-8. PubMed ID: 12850382
[No Abstract] [Full Text] [Related]
16. Tandem duplication of the MLL gene in myelodysplastic syndrome-derived overt leukemia with trisomy 11.
Yamamoto K; Hamaguchi H; Nagata K; Kobayashi M; Taniwaki M
Am J Hematol; 1997 May; 55(1):41-5. PubMed ID: 9136917
[TBL] [Abstract][Full Text] [Related]
17. Frequency and clinical significance of the MLL gene rearrangements in infant acute leukemia.
Taki T; Ida K; Bessho F; Hanada R; Kikuchi A; Yamamoto K; Sako M; Tsuchida M; Seto M; Ueda R; Hayashi Y
Leukemia; 1996 Aug; 10(8):1303-7. PubMed ID: 8709635
[TBL] [Abstract][Full Text] [Related]
18. Immunoreactivity of MIC2 (CD99) and terminal deoxynucleotidyl transferase in bone marrow clot and core specimens of acute myeloid leukemias and myelodysplastic syndromes.
Kang LC; Dunphy CH
Arch Pathol Lab Med; 2006 Feb; 130(2):153-7. PubMed ID: 16454553
[TBL] [Abstract][Full Text] [Related]
19. HRX gene rearrangement in secondary acute lymphoblastic leukemia.
Kobayashi Y; Hayashi Y; Ozawa K; Asano S
Leuk Lymphoma; 1995 May; 17(5-6):391-9. PubMed ID: 7549829
[TBL] [Abstract][Full Text] [Related]
20. Expression analyses identify MLL as a prominent target of 11q23 amplification and support an etiologic role for MLL gain of function in myeloid malignancies.
Poppe B; Vandesompele J; Schoch C; Lindvall C; Mrozek K; Bloomfield CD; Beverloo HB; Michaux L; Dastugue N; Herens C; Yigit N; De Paepe A; Hagemeijer A; Speleman F
Blood; 2004 Jan; 103(1):229-35. PubMed ID: 12946992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
